SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-15-001409
Filing Date
2015-03-06
Accepted
2015-03-06 17:15:21
Documents
4
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A atra-10ka_20141231.htm 10-K/A 43238
2 EX-21.1 atra-ex211_201412318.htm EX-21.1 3674
3 EX-31.1 atra-ex311_201412316.htm EX-31.1 5695
4 EX-31.2 atra-ex312_201412317.htm EX-31.2 5891
  Complete submission text file 0001564590-15-001409.txt   59505
Mailing Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005 415-287-2410
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36548 | Film No.: 15682575
SIC: 2836 Biological Products, (No Diagnostic Substances)